Cassaday & Co Wealth Management LLC increased its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,025 shares of the company’s stock after acquiring an additional 356 shares during the period. Cassaday & Co Wealth Management LLC’s holdings in Procter & Gamble were worth $3,122,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the business. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the second quarter worth $29,000. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the second quarter worth $34,000. Quest Partners LLC bought a new stake in shares of Procter & Gamble in the second quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in shares of Procter & Gamble in the second quarter worth $44,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. This represents a 12.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 25.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 313,597 shares of company stock worth $53,268,499. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The company’s revenue was down .6% on a year-over-year basis. Equities analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.37%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Analyst Ratings Changes
A number of analysts recently issued reports on PG shares. Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. JPMorgan Chase & Co. lifted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Piper Sandler started coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Evercore ISI lifted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.
View Our Latest Research Report on PG
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Most Volatile Stocks, What Investors Need to Know
- Is Boeing Stock a Buy? 5 Pros and 1 Big Risk to Watch in 2024
- What is the S&P/TSX Index?
- Palantir Stock Surges After Announcing Move to the NASDAQ
- Most active stocks: Dollar volume vs share volume
- Why Buffett Dumped Apple and Bet Big on Domino’s Stock Instead
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.